Fresenius Medical Care AG (LON:0H9X)

Market Cap	8.28B -37.4%
Revenue (ttm)	16.90B -0.7%
Net Income	824.87M +52.8%
EPS	2.88 +56.3%
Shares Out	n/a
PE Ratio	10.04
Forward PE	27.49
Dividend	1.29 (3.46%)
Ex-Dividend Date	May 22, 2026

Volume	5,504
Open	36.17
Previous Close	36.32
Day's Range	35.69 - 36.28
52-Week Range	34.60 - 50.92
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 108,165
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2025, Fresenius Medical Care AG's revenue was 19.63 billion, an increase of 1.51% compared to the previous year's 19.34 billion. Earnings were 978.37 million, an increase of 81.88%.

Financial numbers in EUR